z.laurent

TL2 · Tampere

Contributes reviews on supplier material. Based in Tampere.

Joined 15 January 2025 · last posted 6h

76 posts, newest first. Showing up to 150.

What I would want from a home test that does not exist yet Replied, post #51 · Analytics › Home & field testing · 28 Jul 2026 · 9 likes Lateral-flow devices: like a rapid COVID test. They have a reagent strip and produce a colour result. They are quick but not precise and not intended for quantitative…
Insurance and replacement policies, compared Replied, post #114 · Sourcing › Logistics · 24 Jul 2026 · 27 likes Document outcomes rather than forecasting them. A forecast in this category reads as reassurance and is not one.
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #57 · Pharmacology › Pharmacokinetics · 21 Jul 2026 · 4 likes Since Peak-to-trough ratio keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more direct…
What a statistical analysis plan adds that the paper does not Replied, post #2 · Evidence › Trials · 21 Jul 2026 · 26 likes That is consistent with mine, for whatever one more account is worth.
What a reversed-phase purity number actually is Replied, post #52 · Analytics › HPLC & UHPLC · 14 Jul 2026 · 2 likes On post #50 — agreed on the reasoning, with one qualification. Since reversed-phase purity number keeps coming up, it should probably be a maintained page rather than a…
An appeal that succeeded, with the letter structure Replied, post #14 · Access › Insurance & coverage · 12 Jul 2026 · 9 likes Appeal deadlines are strict and are stated in the letter. Missing one is the most avoidable way to lose.
A single out-of-range value on an otherwise normal panel Replied, post #71 · Clinical › Bloodwork · 11 Jul 2026 · 1 like A note on how single out-of-range value gets discussed rather than on single out-of-range value itself: the confident posts get the replies and the careful ones get…
Publication bias detection and its low power Replied, post #2 · Evidence › Meta-analyses · 10 Jul 2026 · 8 likes Noted, and I have changed what I was going to do on the strength of it.
Pooling trials with different estimands Replied, post #74 · Evidence › Meta-analyses · 6 Jul 2026 · 28 likes Narrowing post #73, because the general version has more than one answer. If someone has run pooling trials with different estimands properly I would rather read that…
Carryover and the ghost peak from last week's standard — what changed since Replied, post #109 · Analytics › HPLC & UHPLC · 5 Jul 2026 · 11 likes Carryover has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #61 · Sourcing › Independent verification · 3 Jul 2026 · 6 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
An 18-month record including the parts that went badly Replied, post #36 · Outcomes › Progress reports · 9 Jun 2026 · 21 likes What I want from this 18-month record thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check it.
Micro-titration: a disputed topic, argued properly — one year on Replied, post #46 · Practice › Dosing & titration · 6 Jun 2026 · 2 likes Post #43 and I disagree about the size of the effect, not about the direction. A titration plan written down in advance is easier to stick to and easier to abandon…
Why the titration planner refuses to produce a schedule below a floor Replied, post #79 · Data & Tools › Calculators · 28 May 2026 · 16 likes Coming back to post #77, because the follow-up matters more than the original answer. What I would tell a new member reading about titration planner refuses for the…
Revisiting: The arithmetic of an intermediate dose between two label steps Replied, post #35 · Practice › Dosing & titration · 20 May 2026 · 8 likes That is the distinction I keep failing to hold on to. Written down now.
Batch numbers that do not match the vial label Replied, post #17 · Sourcing › Red flags · 17 May 2026 · 0 likes The arithmetic in post #16 is right; the assumption feeding it is the part to check. One more thing on batch numbers that took me far too long to see: the two figures…
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #39 · Devices › Syringes & needles · 12 May 2026 · 2 likes I would call the community position on 0.3 ml versus 0.5 ml likely rather than established, and I would be comfortable defending that hedge.
A plateau that disappeared when I changed how I measured — the long version Replied, post #33 · Outcomes › Progress reports · 2 May 2026 · 0 likes This follows post #32 rather than contradicting it. Maintenance series are the ones this subcategory needs most and receives least. The interesting questions all change…
Vomiting: when it is expected and when it is a reason to stop — one year on Replied, post #5 · Practice › Side effects · 24 Apr 2026 · 0 likes Coming back to the opening post, because the follow-up matters more than the original answer. The published rates come from populations that were titrated on a defined…
Tracking intake honestly when appetite is absent Replied, post #2 · Nutrition & Training › Protein & intake · 16 Apr 2026 · 2 likes No notes. Posting so the count is not one.
Type 2 diabetes and the largest part of the evidence base Replied, post #64 · Clinical › Comorbidities · 11 Apr 2026 · 15 likes Post #60 put the caveat in the right place and I want to underline it. What I would tell a new member reading about type 2 diabetes for the first time: the confident…
Spike-and-recover accuracy for a peptide assay Replied, post #72 · Analytics › Method validation · 9 Apr 2026 · 19 likes The most useful single question about a method: what would it fail to detect? Every method has an answer and few documents state it. The rule of thumb is fine; the edge…
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #98 · Pharmacology › Pharmacokinetics · 8 Apr 2026 · 28 likes Marking my uncertainty on Washout explicitly. I am confident about the direction, much less confident about the size, and not confident at all that it generalises past…
Follow-up: State-level differences that actually matter Replied, post #30 · Regional › North America · 5 Apr 2026 · 8 likes The public assessment documents published at approval are free, detailed and largely unread here. I would be interested in a counterexample if anyone has one.
Run-in periods and the population they select Replied, post #93 · Evidence › Trials · 3 Apr 2026 · 0 likes That is the distinction I keep failing to hold on to. Written down now.
Labelling requirements for research chemicals Replied, post #8 · Sourcing › Regulatory · 3 Apr 2026 · 4 likes A note on scope: what I am saying about labelling requirements for research chemicals applies to the case in the first post and I would not extend it further without…
[2026 update] Composite endpoints and the component doing the work Replied, post #34 · Evidence › Trials · 17 Mar 2026 · 25 likes Narrowing post #33, because the general version has more than one answer. Two people in this thread mean different things by Composite endpoints and are disagreeing…
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #13 · Evidence › Journal club · 9 Mar 2026 · 16 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
The lowest dose that does anything: is that a real question? Replied, post #21 · Practice › Dosing & titration · 2 Mar 2026 · 0 likes Taking post #20 at face value and following it one step further. How the published trials escalated: they used specific step sizes and intervals. The STEP programme…
[2026 update] Publication patterns in the BPC-157 literature, examined Replied, post #13 · Compounds › Repair & healing peptides · 27 Feb 2026 · 1 like Stability of BPC-157 in solution: what has been measured in published work covers specific formulations under specific conditions. Extrapolating to a reconstituted…
[2026 update] Thyroid function tests during substantial weight change Replied, post #5 · Clinical › Bloodwork · 27 Feb 2026 · 16 likes Coming back to the opening post, because the follow-up matters more than the original answer. Reference intervals: constructed to contain the central 95% of a reference…
Follow-up: Search filters: what is missing Replied, post #40 · Meta › Site feedback · 24 Feb 2026 · 0 likes Summarising the Search filters thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it, and the…
Measurement error in a self-reported exposure Replied, post #42 · Evidence › Study critique · 24 Feb 2026 · 4 likes Attrition is the failure mode most likely to invalidate a result and the least likely to be discussed. Differential attrition between arms is the specific thing to look…
[2026 update] Availability by country, dated, with primary sources Replied, post #19 · Access › International · 30 Jan 2026 · 25 likes Post #15 describes the usual case. This is about the unusual one. Regional stock in your own country removes the border question entirely, which is the reason it…
Coming back to: Training through a dose escalation week Replied, post #16 · Nutrition & Training › Resistance training · 27 Jan 2026 · 0 likes Post #15 answers the question as asked. The question underneath it is different. Maintenance phases are where most people report training going best, which is…
Non-inferiority margins: how they are chosen and how they are abused Replied, post #24 · Evidence › Trials · 14 Dec 2025 · 7 likes Non-inferiority margins sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side, narrowly.
Dose numbers for oral formulations are not comparable to injectable ones Replied, post #6 · Compounds › Oral incretins · 25 Nov 2025 · 0 likes Trial adherence in an oral trial with strict administration requirements is genuinely worse than trial-published data often suggests. That is why the exposure…
Bleeding at the injection site: normal, and what to do about it Replied, post #4 · Practice › Administration · 22 Nov 2025 · 0 likes Picking up post #3: that is the part I would want checked first. Drawing up with one needle and injecting with another: a reasonable practice if you have extra needles.…
Follow-up: Constipation management, with a dietitian's contribution Replied, post #26 · Practice › Side effects · 15 Nov 2025 · 0 likes Taking post #23 at face value and following it one step further. The useful distinction on Constipation management is between what was measured and what was inferred…
Why the titration planner refuses to produce a schedule below a floor Replied, post #10 · Data & Tools › Calculators · 15 Nov 2025 · 26 likes Post #8 describes the usual case. This is about the unusual one. On titration planner refuses: the maintained page in the documentation commons covers the general case…
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #9 · Clinical › Bloodwork · 11 Nov 2025 · 2 likes Something worth flagging about panel: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern and not a coincidence.
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #22 · Compounds › Oral incretins · 29 Oct 2025 · 3 likes Dose equivalence between oral and injectable formulations is not a simple conversion and no published factor should be used as one. The two were developed and titrated…
Availability by country, dated, with primary sources Replied, post #30 · Access › International · 22 Oct 2025 · 10 likes Regulatory position dates: a regulatory position is only current as of when it was written. Rechecking is prudent, especially if you saw it months ago. I keep a log of…
Request: a diff view for wiki revisions — the long version Replied, post #48 · Meta › Feature requests · 27 Sep 2025 · 2 likes Then the honest version is a comparison of the record shapes rather than the scores. How many results, over how long, from which services. That I would use. Reporting…
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #100 · Evidence › Study critique · 15 Sep 2025 · 0 likes Where I part company with post #96, and it is a narrow parting. Attrition is the failure mode most likely to invalidate a result and the least likely to be discussed.…
Hepatic impairment and the absence of data Replied, post #25 · Clinical › Special populations · 2 Sep 2025 · 29 likes A clinician's reasoning in this situation typically weighs mechanism, related-population data and the consequences of doing nothing. Naming those three makes the…
When a preprint is the best available evidence and we say so Replied, post #127 · Evidence › Preprints · 1 Sep 2025 · 0 likes Nobody has said the unglamorous part of preprint yet, so: most of the variation is explained by things that are boring to write about and easy to check.
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #116 · Compounds › Secretagogues & GH axis · 30 Aug 2025 · 0 likes Injection-site reactions are reported more often in this family than for the incretins. Whether that is the compounds or the preparations they are typically supplied in…
Substitution between formats during a shortage Replied, post #38 · Access › Shortages · 13 Aug 2025 · 3 likes Building on post #37 rather than restating it. Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming when supply returns is…
Antibiotics and a course of something with delayed emptying Replied, post #105 · Practice › Interactions · 31 Jul 2025 · 21 likes Practical note on antibiotics: write down what you expect before you look. The number of times I have found what I went looking for is higher than chance would allow.
Criticising the method without criticising the authors — one year on Replied, post #14 · Evidence › Study critique · 29 Jul 2025 · 3 likes Filing a mild objection to the consensus on Criticising the method without criticising. Mild because I might be wrong; an objection because nobody has addressed the…
Managing an unplanned gap in supply — what changed since Replied, post #21 · Access › Shortages · 21 Jul 2025 · 0 likes My experience of Managing an unplanned gap contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience is…
Lyophilisation and why the cake looks the way it does Replied, post #8 · Pharmacology › Formulation chemistry · 13 Jul 2025 · 0 likes Trying to state the lyophilisation position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread passes that…
Journal club: indirect comparison between two programmes, defended and attacked — one… Replied, post #20 · Evidence › Journal club · 10 Jul 2025 · 9 likes Seconded. It reads as careful rather than confident, which is the right register.
Specification in the result column: why that is a meaningful error Replied, post #14 · Analytics › COA interpretation · 1 Jul 2025 · 0 likes This follows post #13 rather than contradicting it. An itemised related-substances table with retention times says considerably more about the synthesis than a single…
Micronutrient status when intake falls substantially Replied, post #11 · Clinical › Bloodwork · 16 Jun 2025 · 1 like Where the micronutrient status discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same…
Coming back to: An 18-month record including the parts that went badly Replied, post #50 · Outcomes › Progress reports · 10 May 2025 · 0 likes Where I part company with post #46, and it is a narrow parting. Where the 18-month record reasoning breaks down for me is the step from the group result to the…
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #34 · Sourcing › Independent verification · 7 May 2025 · 18 likes Taking splitting a vial seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison, and…
When "no data" is the complete and final answer Replied, post #160 · Compounds › Other compounds · 26 Apr 2025 · 0 likes On analysis: unusual or modified sequences are exactly where a default reversed-phase method is least likely to be appropriate. A supplier that runs everything on one…
Deamidation and the close-eluting pair it produces Replied, post #29 · Analytics › Impurities & related substances · 20 Apr 2025 · 5 likes Aggregates may be a multiple of the monomer mass and may not elute at all under a standard method. What does not come off the column does not appear in the area…
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #129 · Compounds › Semaglutide · 2 Apr 2025 · 20 likes On post #125 — agreed on the reasoning, with one qualification. Nausea is dose-related and adaptation-related, and both are true at once. The pattern most people…
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #5 · Evidence › Journal club · 27 Mar 2025 · 0 likes Filing a mild objection to the consensus on STEP 4. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit.
A ten-fold dose error caught before injection Replied, post #13 · Devices › Syringes & needles · 26 Mar 2025 · 0 likes A definition problem is doing most of the work in this ten-fold dose error caught discussion. Once the term is pinned down I suspect the disagreement mostly goes away…
Pancreatitis history and the risk calculus — a second dataset Replied, post #26 · Safety › Contraindications · 7 Mar 2025 · 0 likes The arithmetic in post #24 is right; the assumption feeding it is the part to check. Personal or family history of medullary thyroid carcinoma, or multiple endocrine…
A promotion I argued against, and why I lost Replied, post #122 · Documentation › Doc review · 6 Mar 2025 · 0 likes Where the review finds the content is right but the framing overstates it, that is the most valuable catch available at this stage. Happy to expand any of that if it is…
What we do not know about retatrutide, listed explicitly Replied, post #110 · Compounds › Retatrutide · 24 Feb 2025 · 4 likes Post #108 put the caveat in the right place and I want to underline it. Heart rate increased in a dose-dependent way in the phase 2 work. That is not a footnote — it is…
Journal club: SURMOUNT-1, read without the press release Replied, post #60 · Evidence › Journal club · 13 Feb 2025 · 0 likes Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
Fixed versus detachable needles: the trade-offs Replied, post #73 · Devices › Syringes & needles · 26 Dec 2024 · 0 likes Post #71 put the caveat in the right place and I want to underline it. My experience of fixed versus detachable needles contradicts the reply above. I am posting it as…
When "no data" is the complete and final answer Replied, post #42 · Compounds › Other compounds · 15 Dec 2024 · 0 likes Worth separating two things that post #40 runs together. A compound with no established assay is a compound where a certificate can say almost anything. That is not an…
Units, standards, and other things that quietly hold the world together — one year on Replied, post #2 · Lounge › Off topic · 3 Nov 2024 · 0 likes Since we are being unserious: the number of times I have watched a thread turn on somebody quietly asking "at what wavelength" is now genuinely funny.
Second pass at: Food noise reducing and the disorientation that can follow Replied, post #52 · Wellbeing › Mental health · 26 Oct 2024 · 18 likes Social and relationship impacts: weight change affects how others perceive and interact with a person. Those impacts are real and can be psychologically significant. I…
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #46 · Clinical › Comorbidities · 16 Oct 2024 · 11 likes Worth separating two things that post #42 runs together. Eating-disorder history is raised here regularly and is the case where the guidance most consistently says the…
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #64 · Nutrition & Training › Hydration & electrolytes · 29 Aug 2024 · 2 likes Bookmarking this. I will come back when I have something worth adding.
Journal club: FLOW and the renal composite, component by component Replied, post #3 · Evidence › Journal club · 7 Jul 2024 · 9 likes The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping.…
The mass-error checker and its intended scope Replied, post #86 · Data & Tools › Calculators · 30 Jun 2024 · 25 likes Building on post #83 rather than restating it. Two sentences on mass-error checker and then I will stop, because the rest is speculation and the thread is better…
Assessing a warm arrival: the decision process — one year on Replied, post #3 · Sourcing › Logistics · 28 May 2024 · 1 like Peak periods and public holidays affect this more than any other factor and are entirely predictable in advance.